Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial of LEE001 in combination with Chemoembolization in advanced hepatocellular carcinoma was terminated; results posted i…
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: The Phase III Study of Icaritin Versus HUACHANSU PIAN in Hepatocellular Carcinoma Subjects [Phase 3]
A Phase III study comparing Icaritin to Huachansu Pian in advanced HBV-related hepatocellular carcinoma is in Phase 3 with unknown status.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: The Phase II Study of Icaritin in Patients With Advanced Hepatocellular Carcinoma [Phase 2]
Phase II study updates for icartin in advanced hepatocellular carcinoma has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Sintilimab in Combination With IBI305 (Anti-VEGF Monoclonal Antibody) Compared to Sorafenib as the First-Line Treatment for Advanced Hepatocellular Carcinoma. [Phase 2, Phase 3]
A clinical trial evaluating sintilimab with IBI305 versus sorafenib as first-line therapy for advanced hepatocellular carcinoma (PHASE 2/3).…
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence [Phase 2]
Phase 2 trial evaluating pravastatin to delay recurrence of hepatocellular carcinoma in patients with liver cirrhosis was terminated; result…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-01-14Clinical Trial Update: Evaluation Effectiveness and Safety of (cTACE or DEB-TACE + FOLFOX Regimen HAIC) Combined With Camrelizumab and Apatinib Mesylas in the Treatment of Advanced Hepatocellular Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating the combination of cTACE or DEB-TACE plus FOLFOX-based hepatic arterial infusion chemotherapy with camre…
-
CLINICAL_TRIALS trial_result · 2021-01-13Clinical Trial Update: Sorafenib or Lenvatinib Plus HAIC of 130 mg/m² Oxaliplatin, and 5-fu vs Sorafenib or Lenvatinib Plus HAIC of 85mg/m² Oxaliplatin, and 5-fu for Unresectable Advanced HCC: a Randomised Phase 3 Trial [Phase 3]
A randomized Phase 3 trial comparing high-dose versus lower-dose oxaliplatin-containing HAIC regimens combined with sorafenib or lenvatinib …
-
CLINICAL_TRIALS trial_result · 2021-01-11Clinical Trial Update: Assessment of Novel MRI Quantification Free Breathing Technique in Evaluation of Liver Lesions [NA]
A completed clinical trial evaluating a novel free-breathing MRI quantification technique for assessing liver lesions in hepatocellular carc…
-
CLINICAL_TRIALS trial_result · 2020-12-31Clinical Trial Update: A Trial of Lenvatinib Plus Pembrolizumab in Participants With Hepatocellular Carcinoma [Phase 1]
Phase 1 trial evaluating lenvatinib plus pembrolizumab in hepatocellular carcinoma has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-30Clinical Trial Update: A Phase III PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related HCC After Surgical Resection [Phase 3]
Phase III trial in adjuvant treatment of hepatitis virus–related hepatocellular carcinoma after surgical resection was terminated; results p…
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Sintilimab Plus Bevacizumab as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Curative Resection [Phase 3]
Phase 3 trial evaluating sintilimab plus bevacizumab as adjuvant therapy for hepatocellular carcinoma at high risk of recurrence after curat…
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Regorafenib Plus Tislelizumab as First-line Systemic Therapy for Patients With Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 trial exploring regorafenib plus tislelizumab as first-line systemic therapy for advanced hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: Study of Dalantercept and Sorafenib in Patients With Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]
Phase 1/2 trial of dalantercept combined with sorafenib in advanced hepatocellular carcinoma has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer [Phase 1, Phase 2]
Phase 1/2 study evaluating emibetuzumab in combination with ramucirumab in various advanced cancers, with completed status and results poste…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: FGF401 in HCC and Solid Tumors Characterized by Positive FGFR4 and KLB Expression [Phase 1, Phase 2]
Phase 1/2 study of FGF401 in hepatocellular carcinoma and other solid tumors characterized by FGFR4 and KLB expression has completed. Result…
-
CLINICAL_TRIALS trial_result · 2020-12-16Clinical Trial Update: Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma [Phase 3]
Phase 3 trial comparing hepatic arterial infusion of oxaliplatin, fluorouracil/leucovorin to sorafenib in advanced hepatocellular carcinoma …
-
CLINICAL_TRIALS trial_result · 2020-12-16Clinical Trial Update: Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone [Phase 3]
Phase 3 trial comparing vaccinia virus–based immunotherapy plus sorafenib versus sorafenib alone in hepatocellular carcinoma has completed w…
-
CLINICAL_TRIALS trial_result · 2020-12-16Clinical Trial Update: Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone [Phase 3]
Phase 3 trial evaluating vaccinia virus-based immunotherapy plus sorafenib versus sorafenib alone in hepatocellular carcinoma has completed …
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: HAIC of Oxaliplatin, and 2400 mg/m² 5-fu vs HAIC of Oxaliplatin, and 1200 mg/m² 5-fu for Unresectable HCC: a Randomised Phase 3 Non-inferiority Trial [Phase 3]
A Phase 3 randomized non-inferiority trial comparing HAIC with Oxaliplatin plus 2400 mg/m² 5-FU versus HAIC with Oxaliplatin plus 1200 mg/m²…
-
CLINICAL_TRIALS trial_result · 2020-12-10Clinical Trial Update: SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma [NA]
Clinical trial update for SIR-Spheres in unresectable hepatocellular carcinoma; trial terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-07Clinical Trial Update: Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma [Phase 2]
Phase II trial evaluating a combination of temsirolimus and sorafenib in advanced hepatocellular carcinoma has been completed with results p…
-
CLINICAL_TRIALS trial_result · 2020-12-03Clinical Trial Update: Tislelizumab in Combination With TACE in Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 trial exploring tislelizumab in combination with TACE for advanced hepatocellular carcinoma is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2020-12-02Clinical Trial Update: Study of Peretinoin for Suppressing Recurrence of HCV-positive HCC [Phase 3]
Phase 3 trial evaluating peretinoin for suppressing recurrence of hepatitis C virus–positive hepatocellular carcinoma has completed with res…
-
CLINICAL_TRIALS trial_result · 2020-12-02Clinical Trial Update: A Study of LY2157299 in Participants With Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 study of LY2157299 in advanced hepatocellular carcinoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-11-24Clinical Trial Update: A Phase 2a Study of Modified Vaccinia Virus to Treat Sorafenib-naïve Advanced Liver Cancer [Phase 2]
Phase 2a study of Modified Vaccinia Virus for sorafenib-naïve advanced hepatocellular carcinoma has completed with posted results.